PAI-1 mediates the TGF-Β1EGF-induced scatter response in transformed human keratinocytes

Journal of Investigative Dermatology

Volumn 130, Issue 9, 2010, Pages 2179-2190

  Freytag, Jennifer ^a   Wilkins Port, Cynthia E ^a   Higgins, Craig E ^a   Higgins, Stephen P ^a   Samarakoon, Rohan ^a   Higgins, Paul J ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RAS PROTEIN; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL MOTILITY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; EPITHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KERATINOCYTES; MAP KINASE KINASE 1; MAP KINASE SIGNALING SYSTEM; MESODERM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 77955711734     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.106     Document Type: Article

References (75)

1. Akhurst RJ, Balmain A (1999) Genetic events and the role of TGFb in epithelial tumour progression. J Pathol 187:82-90
2. Akiyoshi S, Ishii M, Kawabata M et al. (2001) Targets of transcriptional regulation by transforming growth factor-b: expression profile analysis using oligonucleotide arrays. Jpn J Cancer Res 92:257-268
3. Andreasen PA, Kjøller L, Christensen L et al. (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72:1-22
4. Arts J, Grimbergen J, Toet K et al. (1999) On the role of c-Jun in the induction of PAI-1 gene expression by phorbol ester, serum, and IL-1a in HepG2 cells. Arterioscler Thromb Vasc Biol 19:39-46
5. Bacharach E, Itin A, Keshet E (1998) Apposition-dependent induction of plasminogen activator inhibitor type 1 expression: a mechanism for balancing pericellular proteolysis during angiogenesis. Blood 92:939-945
6. Bajou K, Noël A, Gerard RD et al. (1998) Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4:923-928
7. Bajou K, Masson V, Gerard RD et al. (2001) The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: implications for antiangiogenic strategies. J Cell Biol 152:777-784
8. Bajou K, Maillard C, Jost M et al. (2004) Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth. Oncogene 23:6986-6990
9. Bajou K, Peng H, Laug WE et al. (2008) Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis. Cancer Cell 14:324-334
10. Boukamp P (2005) UV-induced skin cancer: similarities-variations. J Dtsch Dermatol Ges 3:493-503
11. Chen YJ, Lin SC, Kao T et al. (2004) Genome-wide profiling of oral squamous cell carcinoma. J Pathol 204:326-332
12. Christensen L, Wiborg Simonsen AC, Heegaard CW et al. (1996) Immuno-histochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and a2-macroglobulin receptor in human breast carcinomas. Int J Cancer 66:441-452
13. Cui W, Fowlis DJ, Bryson S et al. (1996) TGFb1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86:531-542
14. Davis GE, Pintar Allen KA, Salazar R et al. (2001) Matrix metalloproteinase-1 and-9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction capillary tube regression in three-dimensional collagen matrices. J Cell Sci 114:917-930
15. Degryse B, Neels JG, Czekay RP et al. (2004) The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1. J Biol Chem 279:22595-22604
16. Derynck R, Akhurst RJ, Balmain A (2001) TGF-b signaling in tumor suppression and cancer progression. Nat Genet 29:117-129
17. Ding W, Shi W, Bellusci S et al. (2007) Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-b1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells. J Cell Physiol 212:796-806
18. INK4A and p53 pathways in UVB-irradiated human skin cells. J Invest Dermatol 129:175-183
19. Go C, Li P, Wang XJ (1999) Blocking transforming growth factor b signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis. Cancer Res 59:2861-2868
20. Grotegut S, von Schweinitz D, Christofori G et al. (2006) Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregula-tion of Snail. EMBO J 25:3534-3545
21. Han G, Lu SL, Li AG et al. (2005) Distinct mechanisms of TGF-b1-mediated epithelial-to-mesenchymal transition and metastasis during skin carci-nogenesis. J Clin Invest 115:1714-1723
22. Heldin CH, Landström M, Moustakas A (2009) Mechanism of TGF-b signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr Opin Cell Biol 21:1-11
23. Herszènyi L, Plebani M, Carraro P et al. (1999) The role of cysteine and serine proteases in colorectal carcinoma. Cancer 86:1135-1142
24. Horiuchi K, Le Gall S, Schulte M et al. (2007) Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol Biol Cell 18:176-188
25. Illemann M, Hansen U, Nielsen HJ et al. (2004) Leading-edge myofibroblasts in human colon cancer express plasminogen activator inhibitor-1. Am J Clin Pathol 122:256-265
26. Joo CK, Kim HS, Park JY et al. (2008) Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-b involves multiple signaling pathways. Oncogene 27:614-628
27. Kim ES, Kim MS, Moon A (2005) Transforming growth factor (TGF)-b in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells. Cytokine 29:84-91
28. Klemke RL, Cai S, Giannini AL et al. (1997) Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 137:481-492
29. Kim JT, Joo CK (2002) Involvement of cell-cell interactions in rapid stimulation of Cas tyrosine phosphorylation and Src kinase activity by transforming growth factor-b1. J Biol Chem 277:31938-31948
30. Kretzschmar M, Doody J, Timokhina I et al. (1999) A mechanism of repression of TGFb/Smad signaling by oncogenic Ras. Genes Dev 13:804-816
31. Kutz SM, Higgins CE, Samarakoon R et al. (2006) TGF-b1-induced PAI-1 expression is E-box/USF-dependent and requires EGFR signaling. Exp Cell Res 312:1093-1105
32. Lehman TA, Modali R, Boukamp P et al. (1993) p53 mutations in human immortalized epithelial cell lines. Carcinogenesis 14:833-839
33. Lindberg P, Larsson, Nielsen BS (2006) Expression of plasminogen activator inhibitor-1, urokinase receptor and laminin g-2 chain is an early coordinated event in incipient oral squamous cell carcinoma. Int J Cancer 118:2948-2956
34. Maillard C, Jost M, Rømer MU et al. (2005) Host plasminogen activator inhibitor-1 promotes human skin carcinoma progression in a stage-dependent matter. Neoplasia 7:57-66
35. Moreno-Bueno G, Cubillo E, Sarrió D et al. (2006) Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition. Cancer Res 66:9543-9556
36. Moustakas A, Heldin CH (2007) Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98:1512-1520
37. Mussoni L, Banfi C, Sironi L et al. (2000) Fluvastatin inhibits basal and stimulated plasminogen activator inhibitor 1, but induces tissue type plasminogen activator in cultured human endothelial cells. Thromb Haemost 84:59-64
38. O-Charoenrat P, Rhys-Evans P, Modjtahedi H et al. (2000) Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. Int J Cancer 86:307-317
39. O-Charoenrat P, Rhys-Evans PH, Archer DJ et al. (2002) C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors. Oral Oncol 38:73-80
40. Offersen BV, Nielsen BS, Høyer-Hansen G et al. (2003) The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas. Am J Pathol 163:1887-1899
41. Oft M, Akhurst RJ, Balmain A (2002) Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol 4:487-494
42. Oft M, Peli J, Rudaz C et al. (1996) TGF-b1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 10:2462-2477
43. Ozaki K, Kadomoto R, Asato K et al. (2001) ERK pathway positively regulates the expression of Sprouty genes. Biochem Biophys Res Commun 285:1084-1088
44. Pedersen H, Brunner N, Francis D Østerlind K et al. (1994) Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res 54:4671-4675
45. Peinado H, Olmeda D, Cano A (2007) Snail, ZEB, and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7:415-428
46. Portella G, Cumming SA, Liddell J et al. (1998) Transforming growth factor b is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ 9:393-404
47. Providence KM, Higgins SP, Mullen A et al. (2008) SERPINE1 (PAI-1) is deposited into keratinocyte migration "trails" and required for optimal monolayer wound repair. Arch Dermatol Res 300:303-310
48. 1 transition in human epidermal keratinocytes. J Cell Biochem 99:495-507
49. 1 transition "wound repair" transcriptome in p53 mutant human keratinocytes. J Invest Dermatol 128:749-753
50. Rho O, Beltrán LM, Gimenez-Conti IB et al. (1994) Altered expression of the epidermal growth factor receptor and transforming growth factor-a during multistage skin carcinogenesis in SENCAR mice. Mol Carcinog 11:19-28
51. Sakakibara T, Hibi K, Koike M etal. (2006) Plasminogen activator inhibitor-1 as a potential marker for the malignancy of gastric cancer. Cancer Sci 97:395-399
52. src/MEK-dependent. J Cell Physiol 204:236-246
53. Y845 and Rho/ROCK signaling. J Mol Cell Cardiol 44:527-538
54. Sato M, Kawai-Kowase K, Sato H et al. (2005) c-Src and hydrogen peroxide mediate transforming growth factor-p1-induced smooth muscle cell-gene expression in 10T1/2 cells. Arterio Thromb Vasc Biol 25:341-347
55. Sekimoto G, Matsuzaki K, Yoshida K etal. (2007) Reversible Smad-dependent signaling between tumor suppression and oncogenesis. Cancer Res 67:5090-5096
56. Shimizu T, Izumi H, Oga A etal. (2001) Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. Dermatology 202:203-206
57. Smoller BR (2006) Squamous cell carcinoma: from precursor lesions to high-risk variants. Mod Pathol 19:S88-92
58. Soltaninassab SR, Anhalt KM, Bonds MD et al. (2008) A novel 96-well assay for assessing chemokinetic modulators of cell migration and invasion. Proc Am Assoc Cancer Res 2008:1178
59. Sternlicht MD, Dunning AM, Moore DH etal. (2006) Prognostic value of PAI1 in invasive breast cancer: evidence that tumor-specific factors are more important than genetic variation in regulating PAI1 expression. Cancer Epidemiol Biomarkers Prev 15:2107-2114
60. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7:131-142
61. Tian YC, Chen YC, Chang CT et al. (2007) Epidermal and transforming growth factor-p1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. Exp Cell Res 313:2367-2377
62. Tomakidi P, Stark H-J, Herold-Mende C et al. (2003) Discriminating expression of differentiation markers evolves in transplants of benign and malignant human skin keratinocytes through stromal interactions. J Pathol 200:298-307
63. Uttamsingh S, Bao X, Nguyen KT et al. (2008) Synergistic effect between EGF and TGF-b1 in inducing oncogenic properties of intestinal epithelial cells. Oncogene 27:2626-2634
64. Vairaktaris E, Yapijakis C, Serefoglou Z et al. (2005) Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. Oral Oncol 42:888-892
65. Vasilaki E, Papadimitriou E, Tajadura V et al. (2010) Transcriptional regulation of the small GTPase RhoB gene by TGFb-induced signaling pathways. FASEB J 24:891-905
66. Wang SE, Xiang B, Guix M et al. (2008) Transforming growth factor b engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab. Mol Cell Biol 28:5605-5620
67. Weeks BH, He W, Olson KL et al. (2001) Inducible expression of transforming growth factor b1 in papillomas causes rapid metastasis. Cancer Res 61:7435-7443
68. Wilkins-Port CE, Higgins CE, Freytag J et al. (2007) PAI-1 is a critical upstream regulator of the TGF-b1/EGF-induced invasive phenotype in mutant p53 human cutaneous squamous cell carcinoma. J Biomed Biotechnol 2007:85208
69. Wilkins-Port CE, Ye Q, Mazurkiewicz JE et al. (2009) TGF-b1+EGF-initiated invasive potential in transformed human keratinocytes is coupled to a plasmin/MMP-10/MMP-1-dependent collagen remodeling axis: role for PAI-1. Cancer Res 69:4081-4091
70. Yuspa SH (1998) The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J Dermatol Sci 17:1-7
71. Zavadil J, Böttinger EP (2005) TGF-b and epithelial-to-mesenchymal transitions. Oncogene 24:5764-5774
72. Zavadil J, Bitzer M, Liang D et al. (2001) Genetic programs of epithelial cell plasticity directed by transforming growth factor-b. Proc Natl Acad Sci USA 98:6686-6691
73. Zhang YE (2009) Non-Smad pathways in TGF-b signaling. Cell Res 19: 128-139
74. Zhou HY, Pon YL, Wong AS (2007) Synergistic effects of epidermal growth factor and hepatocyte growth factor on human ovarian cancer cell invasion and migration: role of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase. Endocrinology 148:5195-5208
75. Zuo W, Chen YG (2009) Specific activation of mitogen-activated protein kinase by transforming growth factor-b receptors in lipid rafts is required for epithelial cell plasticity. Mol Biol Cell 20:1020-1029